{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:05:59Z","timestamp":1761156359776,"version":"3.40.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.transci.2017.08.025","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T23:01:50Z","timestamp":1504911710000},"page":"732-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of an algorithm for anti HCV EIA reactivity in blood donor screening in Turkey in the absence of nucleic acid amplification screening"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-1109","authenticated-orcid":false,"given":"Ayse Esra","family":"Karakoc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukiye","family":"Berkem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Irmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Pekcan","family":"Demiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idil","family":"Yenicesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigar","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6nder","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabri","family":"Kemahli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevinc","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Ozcebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum","family":"Ozet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziya Cibali","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2017.08.025_bib0005","series-title":"Red book","article-title":"Microbiology screening, screening of donations\/donors","author":"JPAC Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee","year":"2016"},{"year":"2011","series-title":"Ulusal Kan ve Kan Urunleri Rehberi","author":"Ministry of Health of Turkey","key":"10.1016\/j.transci.2017.08.025_bib0010"},{"article-title":"Ulusal kan ve kan bilesenleri haz\u0131rlama, kullan\u0131m ve kalite guvencesi rehberi","year":"2016","series-title":"Turkiye\u2019de kan tedarik sisteminin guclendirilmesi teknik destek projesi","key":"10.1016\/j.transci.2017.08.025_bib0015"},{"issue":"RR03","key":"10.1016\/j.transci.2017.08.025_bib0020","first-page":"1","article-title":"CDC: guidelines for laboratory testing and result reporting of antibody to hepatitis C virus","volume":"52","author":"Alter","year":"2003","journal-title":"MMWR"},{"issue":"18","key":"10.1016\/j.transci.2017.08.025_bib0025","first-page":"362","article-title":"Testing for HCV infection: an update of Guidance for clinicians and laboratorians","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.transci.2017.08.025_bib0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2893.2012.01617.x","article-title":"Treating hepatitis C. current standard of care and emerging direct-acting antiviral agents","volume":"19","author":"Poordad","year":"2012","journal-title":"J Virol Hepat"},{"key":"10.1016\/j.transci.2017.08.025_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/qjmed\/hcs214","article-title":"Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis","volume":"106","author":"Cooper","year":"2013","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.transci.2017.08.025_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0973-6247.126683","article-title":"Hepatitis C virus: screening, diagnosis and interpretation of laboratory assays","volume":"8","author":"Gupta","year":"2014","journal-title":"Asian J Transfusion Sci"},{"issue":"4","key":"10.1016\/j.transci.2017.08.025_bib0045","first-page":"445","article-title":"Seroprevalence of hepatitis B and C virus: human immunodeficiency virus and syphilis in the blood donors","volume":"38","author":"Mutlu","year":"2004","journal-title":"Mikrobiyol Bul"},{"issue":"6","key":"10.1016\/j.transci.2017.08.025_bib0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/147323000403200613","article-title":"Trends in major transfusion-transmissible infections among blood donors over 17 years in \u0130stanbul: Turkey","volume":"32","author":"Kocak","year":"2004","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.transci.2017.08.025_bib0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10654-006-0001-2","article-title":"Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey","volume":"21","author":"Emekdas","year":"2006","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"10.1016\/j.transci.2017.08.025_bib0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3855\/jidc.2835","article-title":"HbS Ag: anti HCV, HIV \u00bd and syphilis seroprevalance in healthy volunteer blood donors in southeastern Anatolia","volume":"7","author":"Dayan","year":"2013","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.transci.2017.08.025_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1413-8670(10)70009-X","article-title":"HBV, HCV, HIV seroprevalence among blood donors in \u0130stanbul, Turkey: how effective are the changes in the national blood transfusion policies","volume":"14","author":"Acar","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.transci.2017.08.025_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1751-2824.2011.01492.x","article-title":"Recent insights in testing for transfusion transmissible viral infections","volume":"6","author":"Vermeulen","year":"2011","journal-title":"ISBT Sci Ser"},{"issue":"3","key":"10.1016\/j.transci.2017.08.025_bib0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcv.2005.05.013","article-title":"Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0)","volume":"34","author":"Myrmel","year":"2005","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.transci.2017.08.025_bib0080","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1537-2995.2007.01342.x","article-title":"doHCVir Mexican Study Group Hepatitis C antibody intraassay correlation: is retest in duplicate necessary?","volume":"47","author":"Contreras","year":"2007","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T16:53:48Z","timestamp":1535388828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217301763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1473050217301763"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.025","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of an algorithm for anti HCV EIA reactivity in blood donor screening in Turkey in the absence of nucleic acid amplification screening","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}